Range Low Price High Price Comment
30 days $7.14 $9.98 Tuesday, 30th Apr 2024 RXRX stock ended at $7.82. This is 4.63% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 5.93% from a day low at $7.80 to a day high of $8.26.
90 days $7.14 $15.74
52 weeks $4.54 $16.75

Historical Recursion Pharmaceuticals, Inc. prices

Date Open High Low Close Volume
Apr 30, 2024 $8.06 $8.26 $7.80 $7.82 3 738 914
Apr 29, 2024 $8.24 $8.55 $8.09 $8.20 4 005 888
Apr 26, 2024 $7.86 $8.14 $7.68 $8.12 4 320 149
Apr 25, 2024 $7.57 $7.88 $7.48 $7.84 4 245 069
Apr 24, 2024 $8.15 $8.27 $7.89 $7.94 6 987 970
Apr 23, 2024 $7.56 $7.92 $7.55 $7.70 4 808 595
Apr 22, 2024 $7.46 $7.79 $7.21 $7.60 3 750 460
Apr 19, 2024 $7.30 $7.44 $7.14 $7.35 3 912 199
Apr 18, 2024 $7.35 $7.58 $7.27 $7.40 2 855 913
Apr 17, 2024 $7.64 $7.71 $7.44 $7.47 3 349 404
Apr 16, 2024 $7.61 $7.77 $7.51 $7.57 3 771 654
Apr 15, 2024 $8.41 $8.46 $7.77 $7.79 4 922 478
Apr 12, 2024 $8.82 $8.93 $8.32 $8.41 3 356 136
Apr 11, 2024 $8.65 $8.94 $8.50 $8.92 2 989 447
Apr 10, 2024 $8.64 $8.78 $8.41 $8.58 3 680 360
Apr 09, 2024 $9.00 $9.22 $8.95 $9.09 2 541 498
Apr 08, 2024 $8.91 $9.12 $8.79 $9.00 2 963 751
Apr 05, 2024 $8.53 $8.94 $8.41 $8.87 3 406 543
Apr 04, 2024 $9.02 $9.33 $8.71 $8.73 4 669 336
Apr 03, 2024 $8.85 $9.35 $8.72 $8.93 5 980 692
Apr 02, 2024 $8.96 $9.00 $8.67 $8.77 6 659 950
Apr 01, 2024 $9.98 $9.98 $9.33 $9.37 6 480 911
Mar 28, 2024 $10.10 $10.28 $9.94 $9.97 5 186 326
Mar 27, 2024 $10.35 $10.42 $10.07 $10.17 3 916 975
Mar 26, 2024 $10.61 $10.89 $10.31 $10.32 4 985 864
Click to get the best stock tips daily for free!

About Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals. Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 to treat familial... RXRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT